Straits Research Logo- p.jpg
Fungicides Market Size is projected to reach USD 23,393.85 million by 2031, growing at a CAGR of 4.6%: Straits Research New York, United States, March 28, 2024 (GLOBE NEWSWIRE) -- Modern crop protection against fungal diseases must include fungicides. Due to changes in farming practices and technological...
logo.png
Autoimmune Hepatitis Diagnosis and Treatment Market Size to Reach USD 19.15 Bn by 2032
March 28, 2024 11:05 ET | Precedence Research
Ottawa, March 28, 2024 (GLOBE NEWSWIRE) -- The global autoimmune hepatitis diagnosis and treatment market size is calculated at USD 14.33 billion in 2024 and is projected to hit around USD 18.13...
Logo.png
Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009, PF-06838435/fida, Marstacimab, FLT180a, Concizumab, Fitusiran
March 27, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, March 27, 2024 (GLOBE NEWSWIRE) -- Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009,...
Logo.png
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight
March 25, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, March 25, 2024 (GLOBE NEWSWIRE) -- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The rise in the number of people suffering from cirrhosis can be...
Global Smart Insulin Pens Market
Global Smart Insulin Pens Market Report 2024, Featuring Profiles of Companion Medical, Emperra, Eli Lilly, Bigfoot Biomedical, Diamesco, Pendiq, Medtronic, Diabnext, Diabecare and Capillary Biomedical
March 25, 2024 12:13 ET | Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering.The global smart insulin pens market accounted for USD...
Tonix2.jpg
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
March 25, 2024 08:00 ET | Tonix Pharmaceuticals Holding Corp.
TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces appetite and eating Prader Willi syndrome is the most common genetic...
nn_logo_cmyk_blue_small.jpg
Novo Nordisk A/S - share repurchase programme
March 25, 2024 07:58 ET | Novo Nordisk A/S
Bagsværd, Denmark, 25 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
nn_logo_cmyk_blue_small.jpg
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
March 25, 2024 05:59 ET | Novo Nordisk A/S
Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...
Novo Nordisk A/S - A
Novo Nordisk A/S - Articles of Association 2024
March 25, 2024 03:51 ET | Novo Nordisk A/S
Novo Nordisk's Articles of Association 2024 Attachment Articles of Association 21 Mar 2024 ...
Vedtægter for Novo N
Vedtægter for Novo Nordisk A/S 2024
March 25, 2024 03:51 ET | Novo Nordisk A/S
Vedtægter for Novo Nordisk A/S 2024 Vedhæftet fil Vedtægter 21 Mar 2024 ...